floatz AI

floatz AI for Drug Discovery helps surface high-potential drug targets grounded in human genetics, expression patterns, and biological pathways, built for translational success. It integrates human genetics, tissue expression, and pathway analysis to map billions of concepts and identify targets with real translational potential, delivering 3 clinically-relevant targets in 14 days.

Users define their strategic focus (therapeutic area, indication, constraints). floatz then analyzes the opportunity space by combining literature, disease biology, omics data, pathway networks, and competitive intelligence. Finally, floatz curates and shortlists three high-potential targets, providing scientific rationale, referenced data, and expert review in a decision-ready PDF brief within 14 days.